PT FONKO INTERNATIONAL PHARMACEUTICALS sell "Paclitaxel 30, 100, 300"
Basic Information
1.1K
28
20
4.7(9)
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Paclitaxel 30, 100, 300
Details
Other Information
Additional Description:
PT. Fonko International Pharmaceuticals' oncology finished-dosage range includes paclitaxel at 30 mg, 100 mg and 300 mg, indicated for ovarian carcinoma, breast carcinoma, advanced non-small cell lung carcinoma, and AIDS-related Kaposi's sarcoma; contact the company for further information.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment